Диссертация (1174248), страница 20
Текст из файла (страница 20)
Dis. – 2006. – N 43. – P. 994–1000.11184. Laresgoiti-Servitje, E. An immunological insight into the origins of preeclampsia / E. Laresgoiti-Servitje, N. Gomez-Lopez, D. M. Olson // Hum. Reprod.Update. – 2010. – N 16 (5). – P. 510–524.85. Lecarpentier, E. Risk factors of superimposed preeclampsia in women withessential chronic hypertension treated before pregnancy / E. Lecarpentier, V. Tsatsaris,F.
Goffinet [et al.] // PLoS One. – 2013. – N 8 (5). – P. e62140.86. Leslie, K. Early prediction and prevention of preeclampsia / K. Leslie, B.Thilaganathan, A. Papageorghiou // Best Pract. Res. Clin. Obstet. Gynaecol. – 2011. –N 25 (3). – P. 343–354.87. Leung, T. N. Increased maternal plasma fetal DNA concentrations in womenwho eventually develop preeclampsia / T. N. Leung, J. Zhang, T.
K. Lau [et al.] // Clin.Chem. – 2001. – N 47. – P. 137–139.88. Levine, R. J. Two-stage elevation of cell-free fetal DNA in maternal serabefore onset of preeclampsia / R. J. Levine, C. Qian, E. S. Leshane [et al.] // Am. J.Obstet. Gynecol. – 2004. – N 190. – P. 707–713.89. Lisonkova, S. Incidence of preeclampsia: risk factors and outcomesassociated with early-versus late-onset disease / S. Lisonkova, K. S. Joseph // Am. J.Obstet. Gynecol. – 2013 Dec.
– N 209 (6). – P. 544.e1–544.e12.90. Lo Y. M. Presence of fetal DNA in maternal plasma and serum / Y. M. Lo, N.Corbetta, P. F. Chamberlain [et al.] // Lancet. – 1997. – N 350. – P. 485–487.91. Lo, Y. M. Non-invasive prenatal testing using massively parallel sequencingof maternal plasma DNA: from molecular karyotyping to fetal whole-genomesequencing Reprod / Y. M.
Lo // Biomed. Online. – 2013. – N 27. – P. 593–598. – DOI:10.1016/j.rbmo.2013.08.008.92. Lo, Y. M. Genomic Analysis of Fetal Nucleic Acids in Maternal Blood /Y. M. Lo, R. W Chiu // Annu. Rev. Genomics. Hum. Genet. – 2012. – N 13. – P. 285–306. – DOI: 10.1146/annurev-genom-090711-163806.93. Lo, Y. M. Quantitative abnormalities of fetal DNA in maternal serum inpreeclampsia / Y.
M. Lo, T. N. Leung, M. S. Tein [et al.] // Clin. Chem. – 1999. – N 45.– P. 184–188.11294. Lo, Y. M. Quantitative analysis of fetal DNA in maternal plasma and serum:implications for noninvasive prenatal diagnosis / Y. M. Lo, M. S. Tein, T. K. Lau [etal.] // Am. J. Hum. Genet. – 1998. – N 62.
– P. 768–775.95. Love, J. D. The relationship between human serum and human pancreaticDNase I / J. D. Love, R. R. Hewitt // J. Biol. Chem. – 1979. – N 254. – P. 12588–12594.96. Lundqvist-Avall, E. Serum alkaline DNase activity in normal ornonhospitalised individuals / E. Lundqvist-Avall, A. Economidou-Karaoglou, K. Sjovall[et al.] // Clin. Chim. Acta. – 1989. – N 185. – P. 35–44.97. Magee, L. A. Diagnosis, evaluation, and management of the hypertensivedisorders of pregnancy: executive summary / L. A.
Magee, A. Pels, M. Helewa [et al.] //J. Obstet. Gynaecol. Can. – 2014. – N 36 (5). – P. 416–441.98. Mehrabadi, A. Hypertensive disorders of pregnancy and the recent increase inobstetric acute renal failure in Canada: population based retrospective cohort study / A.Mehrabadi, S. Liu, S. Bartholomew [et al.] // BMJ. – 2014. – N 349. – P. g4731.99. Minassian, C. Acute maternal infection and risk of pre-eclampsia: apopulation-based case-control study / C. Minassian, S. L. Thomas, D. J. Williams [etal.] // PLoS One. – 2013. – N 8 (9).
– P. e73047.100. Morikawa, M. Seasonal variation in the prevalence of pregnancy-inducedhypertension in Japanese women / M. Morikawa, T. Yamada, T. Yamada [et al.] // J.Obstet. Gynaecol. Res. – 2014. – N 40 (4). – P. 926–931.101. Mostello, D. Recurrence of preeclampsia: effects of gestational age atdelivery of the first pregnancy, body mass index, paternity, and interval between births /D. Mostello, D. Kallogieri, R.
Tungsiripat [et al.] // Am J. Obstet. Gynecol. – 2008. – N199(1). – P. 55.e1–55.e7.102. Mutter, W. P. Molecular mechanisms of preeclampsia / W. P. Mutter, S. A.Karumanch // Microvasc. Res. – 2008. – N 75 (1). – P. 1–8.103. Myklestad, K. Hypertensive disorders in pregnancy and paternalcardiovascular risk: a population-based study / K. Myklestad, L.
Vatten, K. Salvesen [etal.] // Ann. Epidemiol. – 2011. – N 21 (6). – P. 407–412.113104. Nadano, D. Measurement of deoxyribo nuclease I activity in human tissuesand body fluids by a single radial enzyme on pregnant diffusion method / D. Nadano, T.Yasuda, K. Kishi // Clin. Chem. – 1993. – N 39. – P. 448–452.105.
Nerenberg, K. A. Risks of gestational diabetes and preeclampsia over thelast decade in a cohort of Alberta women / K. A. Nerenberg, J. A. Johnson, B. Leung [etal.] // J. Obstet Gynaecol. Can. – 2013 Nov. – N 35 (11). – P. 986–994.106. Nicolaides K. H. Turning the pyramid of prenatal care. / K. H. Nicolaides //Fetal.
Diagn. Ther. – 2011. – N 29. – P. 183–196.107. Olayemi, O. Influence of duration of sexual cohabitation on the risk ofhypertension in nulliparous parturients in Ibadan: A cohort study / O. Olayemi, D.Strobino, C. Aimakhu [et al.] // Aust. N. Z. J. Obstet. Gynaecol. – 2010. – N 50 (1). – P.40–44.108. Olusanya, B. O. Perinatal outcomes associated with maternal hypertensivedisorders of pregnancy in a developing country / B. O. Olusanya, O. A. Solanke //Hypertens.
Pregnancy. – 2011. – N 31 (1). – P. 120–130.109. Opdahl, S. Risk of hypertensive disorders in pregnancies following assistedreproductive technology: a cohort study from the CoNARTaS group / S. Opdahl, A.Henningsen, A. Tiitinen, [et al.] // Hum. Reprod. – 2015. – N 30 (7).
– P. 1724–1731.110. Opsjon, S. L. Tumor necrosis factor, interleukin-1, and interleukin-6 innormal human pregnancy / S. L. Opsjon, N. C. Wathen, S. Tingulstad [et al.] // Am. J.Obstet. Gynecol. – 1993. – N 169. – P. 397–404.111. Pare, E. Clinical risk factors for preeclampsia in the 21 st / E. Pare / Publishedonline 2016 Apr 19. – DOI: 10.1136/bmj.i1753 2005.112. Park, F. J. Clinical evaluation of a first trimester algorithm predicting therisk of hypertensive disease of pregnancy / F. J. Park, C.
H. Y., Leung L. C. Y. Poon [etal.] // Aust. N. Z. J. Obstet. Gynaecol. – 2013. – N 53 (6). – P. 532–539.113. Payne, B. Assessment, surveillance and prognosis in pre-eclampsia / B.Payne, L. A. Magee, P. von Dadelszen // Best Pract. Res. Clin. Obstet. Gynaecol. –2011. – N 25 (4). – P. 449–462.114114. Perni, U. C. Interpregnancy change in smoking habits and risk ofpreeclampsia: a population-based study / U. C. Perni, A. Wikstrom, S.
Cnattingius [etal.] // Am. J. Hypertens. – 2012. – N 25(3). – P. 372–378.115. Polsani, S. Emerging new biomarkers of pre-eclampsia / S. Polsani, E.Phipps, B. Jim // Adv. Chronic. Kidney. Dis. – 2013. – N 20 (3). – P. 271–279.116. Poon, L. C. Y. Maternal Plasma Cell-Free Fetal and Maternal DNA at 11–13Weeks’ Gestation: Relation to Fetal and Maternal Characteristics and PregnancyOutcomes, a Harris Birthright Research Centre for Fetal Medicine, King’s CollegeHospital, and b Department of Fetal Medicine, University College London Hospital,London, UK / L.
C. Y. Poon, T. Musci, K. Song [et al.]. – San Jose, Calif., USA :Ariosa Diagnostics, 2013.117. Poston, L. Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised lacebo-controlled trial / L. Poston, A. Briley, P. Seed[et al.] // Lancet. – 2006. – N 367 (9517). – P.
1145–1154.118. Reis, F. M. Predictive value of hormone measurements in maternal and fetalcomplications of pregnancy / F. M. Reis, D. D’Antona, F. Petraglia // Endocr. Rev. –2002. – N 23 (2). – P. 230–257.119. Rieger, R. Glossary in Genetics (Classical and Molecular) / R. Rieger, A.Michaelis, M.M. Green, editors. – 5th ed. – New York : Springer-Verlag, 1991.
– P.353–354.120. Rigo, J. Family history of early-onset cardiovascular disorders is associatedwith a higher risk of severe preeclampsia / J. Rigo, T. Boze, Z. Derzsy, [et al.] // Eur. J.Obstet. Gynecol. Reprod. Biol. – 2006. – N 128 (1–2).
– P. 148–151.121. Robillard, P. Association of pregnancy-induced hypertension with durationof sexual cohabitation before conception / P. Robillard, T. Hulsey, J. Perianin [et al.] //Lancet. – 1994. – N 344 (8928). – P. 973–975.122. Romero, R. Amniotic fluid interleukin 1 in spontaneous labour at term / R.Romero, S. T. Parvizi, E. Oyarzum [et al.] // J.
Reprod. Med. – 1990. – N 35. – P. 235–238.115123. Rosenstreich, D. L. A human urine interleukin-1 inhibitor: homology withdeoxyribonuclease I / D. L. Rosenstreich, J. H. Tu, P. R. Kinkade // J. Exp. Med. 1988.– N 168. – P. 1767–1779.124. Schneider, H. Detection of fetal DNA and RNA in placenta-derivedsyncytiotrophoblast microparticles generated in vitro / H. Schneider, S. Hahn // Clin.Chem. – 2004. – N 50.
– P. 2187–2190.125. Sebastian, T. Small for gestational age births among South Indian women:temporal trend and risk factors from 1996 to 2010 / T. Sebastian, B. Yadav, L.Jeyaseelan [et al.] // BMC Pregnancy Childbirth. – 2015. – N 15. – P. 7.126. Seema, S. Fetal specific hyper methylated RASSF1A quantification inpregnancy / S. Seema, K. Sahai, D. Arora [et al.] // J. Matern Fetal Neonatal Med. –2016. DOI: 10.1080/14767058.2016.1188917,earlyonline 1–5.127. Sekizawa, A. Betaglobin DNA in maternal plasma as a molecular marker ofpre-eclampsia / A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
